NR3C1 and Cushing syndrome: Glucocorticoid receptor antagonism in the treatment of Cushing syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the efficacy and safety of relacorilant